Orally administrable acid stable antiulcer benzimidazole derivatives

Inactive Publication Date: 2002-03-28
KOPRAN RES LAB LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

0091] Effect on cysteamine induced duodenal ulcer model
0092] Administration of cysteamine caused some mortality in rats within 24 hour. The rats when died had perforated ulcers. Polymeric benzimidazoles of Examples 1-7 (1.5

Problems solved by technology

wherein each of R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 is as defied above, are known to be unstable at neutral or acidic pH of the gastric fluid and undergo decomposition in gastrointestinal fluid on oral administration resulting in loss of activity.
The method of preparing enteric coated tablets involves provision o

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Orally administrable acid stable antiulcer benzimidazole derivatives
  • Orally administrable acid stable antiulcer benzimidazole derivatives
  • Orally administrable acid stable antiulcer benzimidazole derivatives

Examples

Experimental program
Comparison scheme
Effect test

example 2

[0061] The copolymer (5.0 g) prepared using glycidyl methacrylate and acrylamide was mixed with omeprazole (1.25 g) dissolved in aqueous medium at pH 9.8. The reaction mixture was stirred at 30.degree. C. for 18 hours. The product was filtered washed with water (100 ml.times.5) and dried under vacuum at 45.degree. C. for 12 hours to obtain 5.92 g of the polymer-substituted omeprazole.

example 3

[0062] The copolymer (5.0 g) prepared using glycidyl methacrylate and glycol dimethacrylate was mixed with omeprazole (1.25 g) dissolved in aqueous madium at pH 10.4. The reaction mixture was stirred at 30.degree. C. for 18 hours. The product was filtered washed with water (100 ml.times.5) and dried under vacuum at 45.degree. C. for 12 hours to obtain 6.05 g of the polymer-substituted omeprazole.

example 4

[0063] The procedure of Example 2 was followed using omeprazole (2.5 g) and pH 10.2 instead of omeprazole (1.25 g) and pH 9.8 to obtain 6.45 g of the polymer-substituted omeprazole.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Angleaaaaaaaaaa
Angleaaaaaaaaaa
Angleaaaaaaaaaa
Login to view more

Abstract

Orally administrable acid stable anti-ulcer benzimidazole derivatives which are polymer based. The process of preparation comprises condensing a benzimidazole with a biocompatible partially orally biodegradable synthetic cross linked polymer in aqueous medium at 5°-80° C. and pH 4-11 under inert atmosphere. The weight percentage of benzimidazole with respect to the polymeric benzimidazole is 1-50. The reaction mixture is cooled and the product is isolated and dried at 25°-45° C. There is also provided a formulation of the polymeric benzimidazoles in combination with pharmaceutically acceptable excipients.

Description

[0001] "This is a continuation of International Application No. PCT / IN 00 / 00016, filed Feb. 24, 2000, the contents of which are expressly incorporated by reference herein in its entirety. The International Application is not published and will be published under PCT Article 21(2) in English."[0002] The benzimidazole derivatives are polymeric benzimidazoles of the formula 1: 1[0003] wherein R.sub.6H or CH.sub.3, X=--OCOCH.sub.2COO--, 2[0004] or --CONHCH.sub.2NHCO--, R.sub.7=H, CH.sub.3, C.sub.2H.sub.5 or CONH.sub.2, Y=OH or NH.sub.2, E=--COO--, B is benzimidazole moiety of the formula IIA: 3[0005] wherein each of R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5=H, C.sub.1-12 alkyl, C.sub.6-1.sub.2 (un)substituted aryl C.sub.1-8 alkoxy, C.sub.6-12 aryloxy, C.sub.1-5 alkoxy carbonyl C.sub.6-12 aryloxy carbonyl, C.sub.1-5 alkoxy alkyl, C.sub.6-12 alkoxyaryl, C.sub.1-5 haloalkyl, C.sub.1-5 alkyl, C.sub.1-5 haloalkoxyl alkyl or C.sub.6-12 aryl thioethers, (un) substituted amines or diamines, (...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/22C07D401/12A61K31/4184A61K31/4439A61K31/787A61K47/12A61K47/26A61K47/32A61K47/38A61K47/48A61P1/04C08F8/34C08F20/00
CPCA61K31/787A61P1/04
Inventor MALI, SUBHASHGUPTE, RAJANDESHPANDE, JAYANTRANBHAN, KAMLESH
Owner KOPRAN RES LAB LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products